Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
PD-1 [Biotinylated] : PD-L1 Inhibitor Screening ELISA Assay Pair | ABIN2762507
PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors | Journal for ImmunoTherapy of Cancer | Full Text
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Identifying New Anti-PD-1 Monoclonal Antibody Drug Candidates
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma | Blood Cancer Journal
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
Advertorial: Novel Bioassay to Assess PD-1/PD-L1 Therapeutic Antibodies in Development for Immunotherapy
Screening Inhibitors that Target PD-1/PD-L1 Binding using AlphaLISA
Synergistic anti-tumor efficacy by combination therapy of a self-assembled nanogel vaccine with an immune checkpoint anti-PD-1 antibody - RSC Advances (RSC Publishing)
Antibody Engineering | Review | InvivoGen
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Anti-hPD1 mAbs| Isotype Family | InvivoGen
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
PD1 Antibody Selection Tool | Bio X Cell
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy | Science Advances
Rational Design of Potent Peptide Inhibitors of the PD-1:PD-L1 Interaction for Cancer Immunotherapy | Journal of the American Chemical Society
Development of domain-specific PD-L1 antibodies a-b, To assess PD-L1... | Download Scientific Diagram
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and Degradation | Journal of Medicinal Chemistry
